Argenx Earnings Reports

argenx delivered robust revenue growth in Q1 2025 with product net sales reaching $790 million and reported a net profit of $169 million, reversing a loss from the previous year. Strong momentum in VYVGART launches and expansion supported commercial performance.

Argenx achieved Q4 2024 revenue of $761.2 million, driven by strong VYVGART product sales. Net income reached $774.2 million, reflecting a significant improvement from the prior year’s loss. Diluted EPS was $11.79, while adjusted EPS was $0.93. The company benefited from a one-time tax gain of $725 million, contributing to profitability.